Innovative Automation Solutions for Flow Cytometry, Bioprocessing, and Drug Discovery
News Sep 16, 2008
This system provides automated sample prep and analysis for a range of Guava® Turnkey Assays in 96-well format. The integrated platform, which contains a Guava EasyCyte™ Plus Flow Cytometer, a Hudson Control PlateCrane EX Robotic Arm, and a Hudson Control micro10 Liquid Dispenser, is effortlessly linked together, and controlled using integration software from both Hudson Control Group and Guava Technologies.
"Working closely with Hudson Control Group we have produced a novel platform that offers true walk-away flow cytometry and cellular analysis," said Paul Wheeler, VP of Sales and Marketing for Guava Technologies. "This process has been simplified due to the unique attributes of our microcapillary flow cytometers. The small footprint and sheathless fluidics means our systems are less restricted in their ability to be integrated with external hardware. The lack of bulky sheath fluid and waste tanks, which are required in traditional flow systems, takes away the physical barriers to integration and unattended operation." He added, "This, at a fraction of the cost of a standard liquid handling platform, and provides an exciting new affordable automation option to scientists in a wide range of research, bioprocessing, and drug discovery workflows."
Phil Farrelly, President of Hudson Control Group added ""Hudson is very excited to be working with Guava Technologies on developing innovative solutions that will accelerate results for researchers working in cellular analysis. Hudson's microplate robot for plate feeding, combined with our liquid-handling and scheduler products will enable practical applications of Guava Technologies cytometry that have not been available before. The cooperation between our two companies should have a dramatic symbiotic effect on both companies' value to the life-sciences research community."
The Guava EasyCyte™ Plus System delivers high throughput, multicolour detection for cell analysis and counting directly to your laboratory benchtop. The system runs all turnkey assays from Guava Technologies, including those for cell counting and viability, apoptosis, and cell cycle. Simultaneous four-colour fluorescence detection on the Guava EasyCyte Plus System greatly expands the information obtained from any one well in a 96-well plate, simplifying simultaneous monitoring of extra- and intracellular events that may affect cellular function. The ability to easily integrate with third-party plate handlers makes high throughput flow cytometry a reality.
Integrated Lead Discovery: An Evolving ToolboxNews
A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE